July 16, 2024
U.S. Acellular Dermal Matrices

Global U.S. Acellular Dermal Matrices Market Estimated To Witness High Growth

The U.S. acellular dermal matrices market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period from 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:-

Acellular dermal matrices are used in soft tissue reconstruction and repair procedures. These matrices provide strength and support to soft tissues by acting as a scaffold for cell migration and tissue regeneration. They help reduce scarring and support wound healing by allowing for natural tissue regrowth. The key applications of acellular dermal matrices include breast reconstruction, hernia repair, and treatment of chronic wounds.

Market Dynamics:-

The growth of the U.S. acellular dermal matrices market is attributed to the rising demand for soft tissue repair procedures like breast reconstruction post mastectomy and hernia repair surgeries. According to the American Society of Plastic Surgeons (ASPS), breast reconstruction surgeries increased by 4% from 2015 to 2016 in the U.S. This can be attributed to increasing breast cancer incidences and awareness about reconstructive options after mastectomy. Additionally, according to the HerniaRepair.com, over 800,000 hernia repair procedures are conducted annually in the U.S. Rising obesity rates are fueling the risk of developing hernias, thereby driving the demand for hernia repair surgeries. Furthermore, acellular dermal matrices help provide a natural tissue option with less scarring for soft tissue reconstruction compared to synthetic meshes, bolstering their adoption.

SWOT Analysis:-

  • Strength:
    • Integra LifeSciences Corporation has strong presence and market share in the acellular dermal matrices market.
    • Advanced tissue regeneration and healing capabilities of acellular dermal matrices products.
    • Rising number of cosmetic and reconstructive surgeries in the US driving demand.
  • Weakness:
    • High costs associated with acellular dermal matrices procedures limit their adoption.
    • Stringent regulatory approvals and post-market surveillance requirements add to production costs.
  • Opportunity:
    • Increasing healthcare expenditures in the US providing opportunities for market growth.
    • Expanding application areas such as breast reconstruction and abdominal wall repair procedures.
  • Threats:
    • Availability of alternative products such as autografts and allografts posing competition.
    • Risks associated with transmission of infectious diseases and immunological reactions to graft materials.

Key Takeaways:-

The Global U.S. Acellular Dermal Matrices Market Demand is expected to witness high growth, exhibiting CAGR of 3.8% over the forecast period, due to increasing number of reconstructive and cosmetic procedures in the country.

Regional analysis:

North America is expected to dominate the acellular dermal matrices market during the forecast period. This is attributed to increasing cosmetic surgeries, rising healthcare infrastructure, and growing number of manufacturers in the region.

Key players analysis:

Key players operating in the U.S. Acellular Dermal Matrices market are Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it